Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Agilent Announces $22 Million Investment for Expansion of Newport Plant
Agilent, a leading global developer and manufacturer of analytical instrumentation, has announced its plans to invest in the expansion of its Newport production plant
OLON Invests €22 Million in New Facility, Ventures into the ADC Market
OLON, a global pharmaceutical leader, is constructing a new facility in Milan, Italy for the exclusive production of ultrapotent compounds, reinforcing its industry dominance in APIs
Merck's €35 Million Investment in Scotland Expands Global Commitment to Biosafety Testing
Merck Enhances Biosafety Testing Capabilities in Scotland at Glasgow and Stirling Sites with Groundbreaking Investment
EUROAPI Plans €50 Million Investment in Budapest Site to Address Increasing Demand for Prostaglandins
EUROAPI, a pharmaceutical company has recently revealed its plans to invest 50 million in a new stateoftheart production plant at its Budapest site
Colorcon, Inc. Announces Investment in New Film Coating Manufacturing Facility in Malaysia
Colorcon, Inc is delighted to announce its investment in a brand new manufacturing plant located in Johor State, Malaysia
Major Investment of Over 50 Billion Yen Allocated to Strengthen Bio Manufacturing Facilities and Support Swift Launch of In-House Projects
Chugai Pharmaceutical Co, Ltd TOKYO 4519 will invest 50 billion yen to construct new bio APIs and injection buildings at the Utsunomiya Plant, strengthening its manufacturing capabilities
Aurigene Pharmaceutical Services Expanding Biologics CDMO Capacity with New Biomanufacturing Facility
Aurigene Pharmaceutical Services Limited, a subsidiary of Dr Reddys Laboratories, invests $40 million to construct a new development and manufacturing facility
Boehringer Invests US$285 million in New Chemical Innovation Plant in Germany
Boehringer Ingelheim invests US$285 million investment for a new chemical Innovation Plant at Ingelheim, Germany headquarters
Lilly Invests US$1.5 billion for Manufacturing Facilities Expansion in USA
Lilly has announced a significant investment of US$15 billion in new manufacturing facilities located in North Carolina, Indiana, and Ireland
BeiGene Invests US$700 million in Manufacturing, R&D Facility in USA
BeiGene is investing US$700 million for the construction of its manufacturing, and RD facility in New Jersey, USA
